| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/09/2005 | WO2004103288A3 Method of preventing recurrent miscarriages |
| 06/09/2005 | WO2004084939A8 Hiv-peptide-carrier-conjugates |
| 06/09/2005 | WO2004080403A3 Influenza virus vaccine |
| 06/09/2005 | WO2004045639A8 Live attenuated vaccine against porcine pleuropneumonia |
| 06/09/2005 | WO2004033483A3 Liposomal system and method of using same |
| 06/09/2005 | WO2003094962A3 Ebv vaccine using gp350 antigen |
| 06/09/2005 | US20050124801 Nucleotide sequences coding cell growth factor polypeptides fusions for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/09/2005 | US20050124789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/09/2005 | US20050124573 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 06/09/2005 | US20050124561 Administering fungicide for mucous membrane; asthma therapy |
| 06/09/2005 | US20050124543 Heterologous polypeptide of the TNF family |
| 06/09/2005 | US20050124540 Antigens; induce immunology response; neutralizaton antibodies; prevent infections; diagnosis |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124055 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy |
| 06/09/2005 | US20050124039 Mixing cationic lipid with a polynucleotide, coding for antigenic determinant, thereby forming a cationic lipid-polynucleotide complex; administering complex to animal for eliciting an immune response |
| 06/09/2005 | US20050124037 Nucleic acid molecules encoding proteins which impart the adhesion of Neisseria cells to human cells |
| 06/09/2005 | US20050123999 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 06/09/2005 | US20050123973 Methods for generating monoclonal antibody against fusion protein containing peptide fragment derived from membrane protein |
| 06/09/2005 | US20050123962 Regulated nucleic acids in pathogenesis of alzheimer's disease |
| 06/09/2005 | US20050123949 Transmembrane proteins for use in identifying modulator for treatment of inflammatory, splenic, bone, respiratory and cell proliferative disorders |
| 06/09/2005 | US20050123925 Compositions and methods for the diagnosis and treatment of tumor |
| 06/09/2005 | US20050123918 Mhc class I peptide epitopes from the human 5t4 tumor-associated antigen |
| 06/09/2005 | US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases |
| 06/09/2005 | US20050123596 pH-triggered microparticles |
| 06/09/2005 | US20050123586 Method for improving body weight uniformity and increasing carcass yield in animals |
| 06/09/2005 | US20050123571 Modulation of apoptosis |
| 06/09/2005 | US20050123570 Tyrosine, modified or unmodified allergen, and 3-deactylated monophosphoryl lipid A; treating a patient susceptible to allergy |
| 06/09/2005 | US20050123569 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/09/2005 | US20050123568 Chromatographic purification steps using unbuffered aqueous bases as eluent and subsequent neutralization; low side effect for specific immunotherapy of this pollen allergy; reduced immunoglobulin E binding with simultaneous retention of therapeutically relevant T-cell stimulation |
| 06/09/2005 | US20050123566 Immunomodulatory compounds and methods of use thereof |
| 06/09/2005 | US20050123565 System and method for transdermal vaccine delivery |
| 06/09/2005 | US20050123563 Lipoparticles comprising proteins, methods of making, and using the same |
| 06/09/2005 | US20050123562 Novel composition |
| 06/09/2005 | US20050123561 Recombinant Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine transformed with a vector that expresses an exogenous antigenic protein; vaccine used for initial antigen stimulation in immune induction by plural antigen stimulations; prevention of infectious diseases such as HIV |
| 06/09/2005 | US20050123557 AntiI-protozoal vaccine |
| 06/09/2005 | US20050123556 Vaccine against infectious disease |
| 06/09/2005 | US20050123555 Alphavirus vectors and virosomes with modified HIV genes for use as vaccines |
| 06/09/2005 | US20050123554 derived from Ixodes scapularis; polypeptides designated 4D8, 4F8 and 4E6 |
| 06/09/2005 | US20050123553 Immunogenic for use in diagnosis, vaccination and/or treatment of amyloid fibril disorders such as Alzheimers disease; vaccines |
| 06/09/2005 | US20050123552 Anti-(fibronectin binding site) antibodies, peptides and epitopes that give rise to antibodies that block the binding of fibronectin binding proteins to fibronectin |
| 06/09/2005 | US20050123551 Nucleic acids encoding polypeptides present in normal and neoplastic endometrial cells for use in diagnosis and treatment of endometrial cancer, identifying endometrial tissue; vectors, host cells; vaccines against endometrial cancer |
| 06/09/2005 | US20050123550 Enhances the efficacy and protective immune response of the vaccine by specifically targeting the intradermal compartment of a subject's skin; an antigenic or immunogenic agent and a molecule that enhances the immune response e.g. gelling agent and bioadhesive; no booster shot required |
| 06/09/2005 | US20050123549 E.g. an antibody that binds the CA6 glycotope conjugated to a cytotoxic agent such as a maytansine; kit with instructions for treating cancer and tumors |
| 06/09/2005 | US20050123547 Methods for diagnosis and treatment of epithelial-derived cancers |
| 06/09/2005 | US20050123546 Polynucleotides; engineered Type II anti-CD20 antibodies with altered glycosylation; vectors and host cells; treatment of B cell lymphomas |
| 06/09/2005 | US20050123545 Diagnosis and treatment of malignant neoplasms |
| 06/09/2005 | US20050123544 treating Alzheimer's disease by administering a humanized or chimeric antibody that specifically binds to an epitope within A beta 3-6 and monitoring the response |
| 06/09/2005 | US20050123541 Anti-TNF antibodies, compositions, methods and uses |
| 06/09/2005 | US20050123540 administering synergistic antibodies for treatment of lymphocytic lymphomas and leukemia; immunotherapy |
| 06/09/2005 | US20050123539 administering molecules that block endogenous costimulatory (B7) interactions with cytotoxic t lymphocytes(CTLA4) and/or CD28 antigens |
| 06/09/2005 | US20050123538 nucleotide sequences that code human epidermal growth factor receptors, used for diagnosing and treating cancer |
| 06/09/2005 | US20050123537 Treating cancer and other angiogenic diseases |
| 06/09/2005 | US20050123536 Treatment of immunological disorders using anti-dc30 antibodies |
| 06/09/2005 | US20050123534 Humanised antibodies |
| 06/09/2005 | US20050123533 Prodrugs activated by targeted catalytic proteins |
| 06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
| 06/09/2005 | US20050123522 Monocyte-derived dendritic cell subsets |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | US20050123511 vector comprising heterologous nucleic acid molecules that code antigenic polypeptides |
| 06/09/2005 | US20050123509 Modulating charge density to produce improvements in the characteristics of spray-dried proteins |
| 06/09/2005 | DE10351471A1 Polyvalente Allergievakzine Polyvalent allergy vaccine |
| 06/09/2005 | CA2552553A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 06/09/2005 | CA2548202A1 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 06/09/2005 | CA2547459A1 Modulators of nik-siva complex formation for treating immune disorders |
| 06/09/2005 | CA2547446A1 Solid forms of anti-egfr-antibodies |
| 06/09/2005 | CA2547435A1 Targeting of erb antigens |
| 06/09/2005 | CA2547326A1 Novel muscle growth regulator |
| 06/09/2005 | CA2547165A1 Mutated anti-cd22 antibodies and immunoconjugates |
| 06/09/2005 | CA2547126A1 Substance binding human igg fc receptor iib (fcyriib) |
| 06/09/2005 | CA2546763A1 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 06/09/2005 | CA2546747A1 Ttbks as modifiers of the beta catenin pathway and methods of use |
| 06/09/2005 | CA2546723A1 Ultrasound assisted transdermal vaccine delivery method and system |
| 06/09/2005 | CA2546664A1 Anti-igfr1 antibody therapeutic combinations |
| 06/09/2005 | CA2546654A1 Polynucleotides overexpressed in breast cancer cells, compositions and methods for the therapy and diagnosis of breast cancer |
| 06/09/2005 | CA2546619A1 Il-23 and its receptor; related reagents and methods |
| 06/09/2005 | CA2546580A1 Homogeneous preparations of chimeric proteins |
| 06/09/2005 | CA2546416A1 Use of parasitic biological agents for diseases prevention and control |
| 06/09/2005 | CA2546378A1 Mrna transfected antigen presenting cells |
| 06/09/2005 | CA2546222A1 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
| 06/09/2005 | CA2544532A1 Compositions comprising polypeptides |
| 06/09/2005 | CA2543566A1 B-cell-targeted toxin for immuno response reduction |
| 06/08/2005 | EP1538210A2 Dna-based vaccination of fish by immersion |
| 06/08/2005 | EP1538209A2 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 06/08/2005 | EP1538208A2 Mutants of streptococcal toxin A and methods of use |
| 06/08/2005 | EP1538163A2 Phosphorylated Amyloid-Beta 1-43 Protein and its use in the treatment of Alzheimer's disease |
| 06/08/2005 | EP1537878A1 Immunopotentiating compositions |
| 06/08/2005 | EP1537877A2 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 06/08/2005 | EP1537872A1 Immunostimulator having antineoplastic action and method for producing said immunostimulator |
| 06/08/2005 | EP1537860A1 Vaccine composition, method of preparing the composition and method of vaccinating vertebrates |
| 06/08/2005 | EP1537417A2 Method of diagnosing colon and gastric cancers |
| 06/08/2005 | EP1537243A1 Method of diagnosing ovarian endometriosis |
| 06/08/2005 | EP1537219A2 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 06/08/2005 | EP1537214A2 Regulated bacterial lysis for gene vaccine vector delivery and antigen release |
| 06/08/2005 | EP1537212A2 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 06/08/2005 | EP1537207A2 Recombinant colstridium neurotoxin fragments |
| 06/08/2005 | EP1537206A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/08/2005 | EP1537205A2 Viral deconstruction through capsid assembly in vitro |
| 06/08/2005 | EP1537203A1 USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) |
| 06/08/2005 | EP1537148A1 Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/ or identifying neuronal precursor cells |
| 06/08/2005 | EP1537147A2 Antibody for adcc and inducing cytokine production |